{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T02:28:11Z","timestamp":1786415291070,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cjcopen.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cjco.2026.04.005","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:41:47Z","timestamp":1777074107000},"page":"948-957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting Atrial Fibrillation Risk in Hypertrophic Cardiomyopathy Patients"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1638-6270","authenticated-orcid":false,"given":"Mahdi","family":"Montazeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deacon Z.J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sakhnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Rakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond H.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2026.04.005_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/heartjnl-2013-304276","article-title":"Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review","volume":"100","author":"Guttmann","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.cjco.2026.04.005_bib2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1253\/jcj.61.673","article-title":"Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation","volume":"61","author":"Higashikawa","year":"1997","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.cjco.2026.04.005_bib3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jama.281.7.650","article-title":"Clinical course of hypertrophic cardiomyopathy in a regional United States cohort","volume":"281","author":"Maron","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.cjco.2026.04.005_bib4","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2014.02.555","article-title":"Atrial remodeling and atrial fibrillation: recent advances and translational perspectives","volume":"63","author":"Nattel","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2026.04.005_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.009796","article-title":"Development and validation of a clinical predictive model for identifying hypertrophic cardiomyopathy patients at risk for atrial fibrillation: the HCM-AF score","volume":"14","author":"Carrick","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjco.2026.04.005_bib6","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1378\/chest.09-2335","article-title":"Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"137","author":"Pedrosa","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.cjco.2026.04.005_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1532-429X-11-34","article-title":"CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation","volume":"11","author":"Papavassiliu","year":"2009","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.cjco.2026.04.005_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2003.01.001","article-title":"P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy","volume":"94","author":"Ozdemir","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2026.04.005_bib9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.amjcard.2006.10.046","article-title":"Prognostic significance of exercise induced arrhythmias and echocardiographic variables in hypertrophic cardiomyopathy","volume":"99","author":"Bunch","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2026.04.005_bib10","doi-asserted-by":"crossref","first-page":"13H","DOI":"10.1016\/S0002-9149(99)00251-9","article-title":"Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation","volume":"83","author":"Gruver","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2026.04.005_bib11","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/0002-9149(92)90939-V","article-title":"Degree of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy and chronic atrial fibrillation","volume":"69","author":"Spirito","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2026.04.005_bib12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.cjco.2021.01.016","article-title":"Machine learning methods for identifying atrial fibrillation cases and their predictors in patients with hypertrophic cardiomyopathy: the HCM-AF-risk model","volume":"3","author":"Bhattacharya","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.cjco.2026.04.005_bib13","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jacep.2021.04.004","article-title":"Predictors of major atrial fibrillation endpoints in the national heart, lung, and blood institute HCMR","volume":"7","author":"Kramer","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjco.2026.04.005_bib14","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s10554-021-02232-0","article-title":"The predictive value of left ventricular and left atrial mechanics for atrial fibrillation and heart failure in hypertrophic cardiomyopathy: a prospective cohort study","volume":"37","author":"Zegkos","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.cjco.2026.04.005_bib15","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2026.04.005_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/ehjci\/jey042","article-title":"Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"19","author":"Badano","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cjco.2026.04.005_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1532-429X-14-13","article-title":"Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"14","author":"Maron","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.cjco.2026.04.005_bib18","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2026.04.005_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12968-014-0060-6","article-title":"Quantification of left atrial strain and strain rate using cardiovascular magnetic resonance myocardial feature tracking: a feasibility study","volume":"16","author":"Kowallick","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.cjco.2026.04.005_bib20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2026.04.005_bib21","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.12.045","article-title":"Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance","volume":"113","author":"Maron","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2026.04.005_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4081\/hi.2006.106","article-title":"Effect of hypertrophy on left ventricular diastolic function in patients with hypertrophic cardiomyopathy","volume":"2","author":"Ciampi","year":"2006","journal-title":"Heart Int"},{"key":"10.1016\/j.cjco.2026.04.005_bib23","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.echo.2005.06.011","article-title":"Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity","volume":"18","author":"Yang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cjco.2026.04.005_bib24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.echo.2010.01.022","article-title":"Left atrial phasic volumes are modulated by the type rather than the extent of left ventricular hypertrophy","volume":"23","author":"Eshoo","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cjco.2026.04.005_bib25","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.hrthm.2015.03.042","article-title":"Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"12","author":"Bassiouny","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjco.2026.04.005_bib26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.amjcard.2004.06.024","article-title":"Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy","volume":"94","author":"Losi","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2026.04.005_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2013.10.055","article-title":"Left atrial size and function: role in prognosis","volume":"63","author":"Hoit","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2026.04.005_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/481245","article-title":"Effect of left ventricular outflow tract obstruction on left atrial mechanics in hypertrophic cardiomyopathy","volume":"2015","author":"Williams","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.cjco.2026.04.005_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004052","article-title":"Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation","volume":"10","author":"Debonnaire","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjco.2026.04.005_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12968-021-00793-6","article-title":"Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study","volume":"23","author":"Raman","year":"2021","journal-title":"J Cardiovasc Magn Reson"},{"issue":"Suppl 1","key":"10.1016\/j.cjco.2026.04.005_bib31","article-title":"Left atrial strain as a predictor of atrial fibrillation in hypertrophic cardiomyopathy","volume":"27","author":"Ferreira Neves","year":"2025","journal-title":"Europace"},{"key":"10.1016\/j.cjco.2026.04.005_bib32","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1016\/j.ejrad.2009.12.012","article-title":"Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study","volume":"75","author":"Pujadas","year":"2010","journal-title":"Eur J Radiol"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X26001526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X26001526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T01:35:36Z","timestamp":1786412136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X26001526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589790X26001526"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2026.04.005","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting Atrial Fibrillation Risk in Hypertrophic Cardiomyopathy Patients","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2026.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}